Loading...
Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease
BACKGROUND: Knowledge of possible cardiovascular risks from Parkinson's disease (PD) medications is critical to informing safe and effective treatment decisions. The objective of our study was to determine whether PD patients treated with nonergot dopamine agonists (DAs) are at increased risk o...
Na minha lista:
| Udgivet i: | Mov Disord Clin Pract |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178630/ https://ncbi.nlm.nih.gov/pubmed/30363519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12286 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|